spot_img
5.1 C
London
HomeUncategorizedGSK stock climbs on Delaware court ruling in Zantac case (NYSE:GSK)

GSK stock climbs on Delaware court ruling in Zantac case (NYSE:GSK)


Glaxo Smith Kline headquarters, London

William Barton/iStock Editorial via Getty Images

GSK (NYSE:GSK) stock was up 3% in afternoon trading Tuesday in the wake of a ruling by a Delaware court on whether certain evidence should be allowed in an ongoing case over the safety of its recalled drug Zantac.

In



Source link

latest articles

explore more

LEAVE A REPLY

Please enter your comment!
Please enter your name here